Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI EBITDA Margin

EBITDA as a percentage of revenue.

Sanara MedTech Inc.NASDAQ: SMTI

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 10.0%

EBITDA Margin was 10.0% in Q1 FY2026, up 2.2 pp from a year earlier. On a trailing-twelve-month basis it was 7.7%, up 6.7 pp year over year. Over 3 fiscal years it widened by 34.0 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 23.8% for the fiscal year ending Dec 2026, up from 8.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
10.0%+5.0 pp QoQ
Last fiscal yearDec 2025
8.8%+10.9 pp YoY
LTMMar 2026
7.7%+6.7 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.2 pp+4.2 pp+2.0 pp
1 year+10.9 pp+15.1 pp+4.2 pp
3 years+34.0 pp+10.1 pp-23.9 pp
5 years+4.5 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
8.8%
Year-over-year change
+10.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How SMTI compares with its peers on the latest reported figures

  • SMTI's LTM Mar 2026 EBITDA Margin of 7.7% is the 3rd highest of the 10 companies compared; the peer median is -1.9%.
  • Its year-over-year change of +6.7 pp is the 3rd highest of 10, against a peer median of +0.7 pp.
  • Over three fiscal years its change of +34.0 pp compares with a peer median of +9.0 pp.
SMTI Competitors Peer median
EBITDA Margin for SMTI and competitors
Company Period LTM level YoY 3-year change
VMDViemed Healthcare, Inc.LTM Mar 202618.5% +0.7 pp+1.2 pp
TBRGTruBridge, Inc.LTM Mar 20269.4% -3.3 pp-2.4 pp
SMTISanara MedTech Inc.LTM Mar 20267.7% +6.7 pp+34.0 pp
NEONeoGenomics, Inc.LTM Jun 20261.7% +5.8 pp+10.8 pp
HITIHigh Tide Inc.LTM Apr 2026-0.9% -5.9 pp+7.1 pp
LFMDLifeMD, Inc.LTM Mar 2026-1.9% -3.3 pp+31.6 pp
XGNExagen Inc.LTM Mar 2026-18.9% +1.5 pp+75.6 pp
SGHTSight Sciences, Inc.LTM Mar 2026-39.8% +16.3 pp+70.4 pp
STXSStereotaxis, Inc.LTM Mar 2026-64.4% +23.4 pp+1.4 pp
TRDAEntrada Therapeutics, Inc.LTM Mar 2026-2873.3% -2889.4 pp—
Peer median (excluding SMTI) -1.9%+0.7 pp+9.0 pp

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.14M45.84M64.99M86.67M103.12M
Cost of Revenue2.31M6.36M7.85M8.14M10.18M
Gross Profit21.83M39.48M57.14M78.53M92.94M
Gross Margin90.4%86.1%87.9%90.6%90.1%
Research & Development558.7K3.37M4.13M5.7M5.07M
Selling, General & Admin28.05M45.98M56.99M76.56M78.72M
Operating Expenses29.21M52M61.35M85.25M83.79M
Depreciation & Amortization771.93K2.37M3.68M4.92M2.66M
EBITDA(7.22M)(11.57M)(289.1K)(1.86M)9.03M
EBITDA Margin-29.9%-25.2%-0.4%-2.1%8.8%
Operating Income(7.38M)(12.52M)(4.22M)(6.72M)9.15M
Operating Margin-30.6%-27.3%-6.5%-7.7%8.9%
Interest Income0284.75K021.98K3.67K
Interest Expense711284.75K475.78K3.13M6.76M
Other Income / Expenses(617.64K)(1.42M)(224.75K)(3.2M)(9.54M)
Income Before Tax(7.99M)(13.94M)(4.44M)(9.91M)(393.12K)
Pre-Tax Margin-33.1%-30.4%-6.8%-11.4%-0.4%
Income Tax Expense0(5.84M)000
Net Income(7.92M)(7.94M)(4.3M)(9.66M)(37.56M)
Net Margin-32.8%-17.3%-6.6%-11.2%-36.4%
EPS (Basic)(1.08)(1.00)(0.52)(1.14)(4.36)
EPS (Diluted)(1.08)(1.00)(0.52)(1.14)(4.36)
Weighted Avg Shares7.34M7.91M8.28M8.48M8.62M
Weighted Avg Shares (Diluted)7.34M7.91M8.28M8.48M8.62M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.